Tvardi Therapeutics (TVRD) Misses Q4 EPS by 78c

March 31, 2026 5:00 PM EDT

Tvardi Therapeutics (NASDAQ: TVRD) reported Q4 EPS of ($0.78).

For earnings history and earnings-related data on Tvardi Therapeutics (TVRD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK